Amphastar Pharma (AMPH) Tops Q3 EPS by 5c

Amphastar Pharma (NASDAQ: AMPH) reported Q3 EPS of $0.07, $0.05 better than the analyst estimate of $0.02. Revenue for the quarter came in at $57.9 million versus the consensus estimate of $57.2 million.

For earnings history and earnings-related data on Amphastar Pharma (AMPH) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Alphabet slides over 6% as AI brain drain and SpaceX slump converge
• Ennis (EBF) Reports In-Line Q1 EPS